DK3008172T3 - Dyrkningsmedium-sammensætninger til modning af cardiomyocytter afledt fra pluripotente mammale stamceller - Google Patents

Dyrkningsmedium-sammensætninger til modning af cardiomyocytter afledt fra pluripotente mammale stamceller Download PDF

Info

Publication number
DK3008172T3
DK3008172T3 DK14732446.1T DK14732446T DK3008172T3 DK 3008172 T3 DK3008172 T3 DK 3008172T3 DK 14732446 T DK14732446 T DK 14732446T DK 3008172 T3 DK3008172 T3 DK 3008172T3
Authority
DK
Denmark
Prior art keywords
mammale
cardiomyocyts
maturing
pluripotent
derived
Prior art date
Application number
DK14732446.1T
Other languages
English (en)
Inventor
Stefan Robbert Braam
Original Assignee
Ncardia B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncardia B V filed Critical Ncardia B V
Application granted granted Critical
Publication of DK3008172T3 publication Critical patent/DK3008172T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK14732446.1T 2013-06-11 2014-06-06 Dyrkningsmedium-sammensætninger til modning af cardiomyocytter afledt fra pluripotente mammale stamceller DK3008172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2010953 2013-06-11
PCT/NL2014/050366 WO2014200339A1 (en) 2013-06-11 2014-06-06 Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells

Publications (1)

Publication Number Publication Date
DK3008172T3 true DK3008172T3 (da) 2020-07-20

Family

ID=50981826

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14732446.1T DK3008172T3 (da) 2013-06-11 2014-06-06 Dyrkningsmedium-sammensætninger til modning af cardiomyocytter afledt fra pluripotente mammale stamceller

Country Status (11)

Country Link
US (2) US10696947B2 (da)
EP (2) EP3708655A1 (da)
JP (4) JP6682429B2 (da)
CN (1) CN105473708A (da)
CA (2) CA2914922C (da)
DK (1) DK3008172T3 (da)
ES (1) ES2806698T3 (da)
HU (1) HUE049916T2 (da)
PL (1) PL3008172T3 (da)
PT (1) PT3008172T (da)
WO (1) WO2014200339A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3708655A1 (en) * 2013-06-11 2020-09-16 Ncardia B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells
EP3152300A1 (en) 2014-06-06 2017-04-12 Pluriomics B.v. Cardiomyocyte maturation
EP3204490A1 (en) 2014-10-07 2017-08-16 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells
US10613078B2 (en) 2015-02-20 2020-04-07 Ncardia B.V. Assays for measuring cardiotoxicity
PL3344758T3 (pl) 2015-09-01 2022-01-03 Ncardia B.V. Sposób in vitro różnicowania populacji ludzkich pluripotentnych komórek macierzystych w populację komórek kardiomiocytów
CN105567635A (zh) * 2016-02-21 2016-05-11 中国医科大学附属第一医院 一种改良的Neurobasal B27培养基、制备方法及应用
EP3504321A4 (en) * 2016-08-26 2020-03-11 The University of Queensland MATURATION OF CARDIOMYOCYTES
CN106754663A (zh) * 2016-11-30 2017-05-31 中国人民解放军第三军医大学第三附属医院 促进成年哺乳动物心肌细胞存活的体外培养方法及监测成年哺乳动物心肌细胞增殖的方法
CN106957815B (zh) * 2017-03-16 2021-05-07 杨涛 一种用于人类多潜能干细胞的无血清培养基的配方
NL2019618B1 (en) 2017-09-22 2019-03-28 Ncardia B V In vitro method for providing stem cell derived cardiomyocytes
CN108456654A (zh) * 2018-02-22 2018-08-28 上海产业技术研究院 用于促进干细胞来源心肌细胞成熟的无血清培养体系
IL277340B1 (en) * 2018-03-30 2024-03-01 Univ Kyoto Modified isoindolinone-benzimidazole compounds, a cardiomyocyte maturation promoter, and a method for preparing an adult cardiomyocyte
CN111918961B (zh) * 2018-03-30 2023-10-24 国立大学法人京都大学 心肌细胞成熟促进剂
EP3980037A4 (en) * 2019-06-06 2023-06-21 President and Fellows of Harvard College CARDIAC MYOCYTES AND COMPOSITIONS AND METHODS OF PRODUCTION THEREOF
CN111454886A (zh) * 2020-05-12 2020-07-28 广东源心再生医学有限公司 一种增强型心肌细胞培养液及其应用
CN112708591B (zh) * 2020-12-24 2022-04-29 南京周子未来食品科技有限公司 一种用于肌肉干细胞体外分化的化学成分明确的培养基
CN113073076B (zh) * 2021-04-24 2022-09-09 华中科技大学同济医学院附属协和医院 一种将多能干细胞分化为瓣膜内皮细胞与瓣膜***的分化方法
CN113215085B (zh) * 2021-05-07 2024-05-10 澳门大学 一种脂类物质添加剂及其应用
WO2023114274A1 (en) * 2021-12-14 2023-06-22 Agex Therapeutics, Inc. Improved methods for inducing the maturation of mammalian cells
WO2023136229A1 (ja) * 2022-01-11 2023-07-20 三井化学株式会社 薬剤の、心筋細胞に対する作用を評価する方法
WO2024004960A1 (ja) * 2022-06-27 2024-01-04 武田薬品工業株式会社 細胞の培養方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871206D1 (de) 1987-03-24 1992-06-25 Grace W R & Co Basisnaehrmedium fuer eine zellkultur.
AU632065B2 (en) 1988-09-23 1992-12-17 Novartis Vaccines And Diagnostics, Inc. Cell culture medium for enhanced cell growth, culture longevity and product expression
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
US6221911B1 (en) * 1995-06-07 2001-04-24 Karo Bio Ab Uses for thyroid hormone compounds or thyroid hormone-like compounds
US7425448B2 (en) * 2001-07-12 2008-09-16 Geron Corporation Cardiomyocyte precursors from human embryonic stem cells
JP2005515777A (ja) * 2002-01-25 2005-06-02 ジェンザイム・コーポレーション 軟骨細胞のための無血清培地およびその使用法
WO2004098490A2 (en) 2002-05-17 2004-11-18 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
CA2391118A1 (en) 2002-06-21 2003-12-21 Universite Du Quebec A Montreal Oxytocin as cardiomyogenesis inducer and uses thereof
US9101590B2 (en) * 2005-07-29 2015-08-11 Yale University Defined culture conditions of human embryonic stem cells
JP2007124982A (ja) * 2005-11-07 2007-05-24 Toray Ind Inc 細胞培養液および細胞培養方法
JP2007228815A (ja) * 2006-02-27 2007-09-13 Gifu Univ 胚性幹細胞の維持方法
GB0622395D0 (en) * 2006-11-09 2006-12-20 Univ Cambridge Tech Methods relating to pluripotent cells
GB0622394D0 (en) * 2006-11-09 2006-12-20 Univ Cambridge Tech Differentiation of pluripotent cells
CN100540659C (zh) * 2006-12-22 2009-09-16 北京维通达生物技术有限公司 一种培养小鼠胚胎干细胞的方法及其专用培养基
AU2008205459A1 (en) * 2007-01-19 2008-07-24 Mount Sinai School Of Medicine Of New York University Stem cell gene targeting
CA2676044C (en) * 2007-01-30 2019-10-22 University Of Georgia Research Foundation, Inc. Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
EP2139988A1 (en) * 2007-03-15 2010-01-06 California Stem Cell, Inc. Cardiomyocytes and methods of producing and purifying cardiomyocytes
WO2010007031A2 (en) * 2008-07-14 2010-01-21 Novartis Ag Methods for improving cardiac differentiation of human embryonic stem cells
US10894944B2 (en) * 2009-04-10 2021-01-19 Monash University Cell culture media
EP2488631B1 (en) 2009-10-13 2020-01-08 Stemcell Technologies Inc. Manipulation of osmolality for differentiating stem cells
ES2779048T3 (es) * 2009-11-12 2020-08-13 Technion Res & Dev Foundation Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
WO2011100286A2 (en) * 2010-02-09 2011-08-18 The Johns Hopkins University Compositions and methods of generating a differentiated mesodermal cell
CN103141077B (zh) * 2010-09-29 2016-01-20 夏普株式会社 信号处理装置、控制程序以及集成电路
US20140178894A1 (en) * 2011-04-20 2014-06-26 Novartis Forschungsstiftung, Zweigniederlassung Culture medium suitable for the culture of undifferentiated cells
JP2014521337A (ja) 2011-07-29 2014-08-28 セルラー ダイナミクス インターナショナル， インコーポレイテッド 幹細胞由来の組織細胞中の代謝成熟
EP2808383B1 (en) * 2012-01-27 2018-07-25 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell
CN103365555A (zh) * 2012-03-31 2013-10-23 国际商业机器公司 数据处理方法和***、数据收集方法和***
EP3708655A1 (en) * 2013-06-11 2020-09-16 Ncardia B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells

Also Published As

Publication number Publication date
CA3135208A1 (en) 2014-12-18
EP3708655A1 (en) 2020-09-16
US10696947B2 (en) 2020-06-30
HUE049916T2 (hu) 2020-11-30
US20160122718A1 (en) 2016-05-05
JP2024040143A (ja) 2024-03-25
PT3008172T (pt) 2020-07-21
WO2014200339A1 (en) 2014-12-18
ES2806698T3 (es) 2021-02-18
EP3008172A1 (en) 2016-04-20
PL3008172T3 (pl) 2020-09-21
JP2020022460A (ja) 2020-02-13
CN105473708A (zh) 2016-04-06
JP2022031684A (ja) 2022-02-22
EP3008172B1 (en) 2020-05-06
JP6682429B2 (ja) 2020-04-15
US20200370018A1 (en) 2020-11-26
JP2016521571A (ja) 2016-07-25
CA2914922C (en) 2021-11-30
CA2914922A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
DK3008172T3 (da) Dyrkningsmedium-sammensætninger til modning af cardiomyocytter afledt fra pluripotente mammale stamceller
IL250340A0 (en) Growth media for the culture of pluripotent stem cells
DK3702443T3 (da) Sammensætninger og fremgangsmåder til opformering og dyrkning af epiteliale stamceller
DK2981607T3 (da) Effektiv generering af tumormålrettede t-celler afledt af pluripotente stamceller
DK3116902T3 (da) Fremgangsmåde til generering af T-celler kompatible for allogen transplantation
DK3224351T3 (da) Dyrkningsmedium til ekspandering af brystepitelstamceller
DK2934187T3 (da) Økonomisk fremgangsmåde til isolering af funktionelt protein fra planter
DK2872152T3 (da) Acellulære pro-tolerogene sammensætninger til behandling/forebyggelse af transplantatafstødning
DK2906696T3 (da) Fremgangsmåder til modulering af c9orf72-ekspression
DK3512197T5 (da) Fremgangsmåde til kortlægning af intraprædikationsmodus
DK2885776T3 (da) Anlæg til fremme af hygiejniske forhold
DK2665486T3 (da) Sammensætninger til modulering af gamma-c-cytokin-aktivitet
DK3080304T3 (da) Fremgangsmåde til fremstillingen af sukre fra biomasse
SMT201500147B (it) Cellule staminali stromalo
HK1222200A1 (zh) 製備多能幹細胞的方法
EP3060650A4 (en) Culturing pluripotent stem cells
DK3064574T3 (da) Fremgangsmåde til differentiering af pluripotente stamceller induceret fra mesenkymstamceller til chondrocyt
DK3064575T3 (da) Fremgangsmåde til differentiering af pluripotent stamcelle induceret fra mesenkymal stamcelle til hepatocyt
DK2802204T3 (da) Modulering af plantebiologi
HK1247639A1 (zh) 培養幹細胞的培養基組合物
DK3172317T3 (da) Fremgangsmåde til oprensning af poliovirus fra cellekulturer
DK3064573T3 (da) Fremgangsmåde til differentiering af pluripotent stamcelle induceret fra mesenkymal stamcelle til neuron
DK2983680T3 (da) Forbedring af organer til transplantation
EP2949746A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS
DK2897454T3 (da) Fremgangsmåder og sammensætninger til forlængelse af planteprodukters holdbarhed